Sperimentazione in fase di reclutamento = ; Sperimentazione in corso = ; Finanziato da un ente associato a IRDiRC =

Sperimentazioni cliniche nazionali

FRANCIA

ILE-DE-FRANCE
PARIS

Randomised cross-over double blind versus placebo trial followed by an open phase studying effect of Norditropin on left ventricular mass of growth hormone deficient adult patients (Phase IV) - Terminated -

CHU Paris Est - Hôpital Saint-Antoine

Service d'endocrinologie-médecine de la reproduction

Ulteriori dettagli

SPAGNA

Cataluña
BARCELONA

A randomised, open-labelled, single dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics of pegylated long-acting human growth hormone (NNC126-0083) compared to norditropin NordiFlex® in growth hormone deficient children (Phase II) (terminated)

Hospital Universitari Vall d'Hebron - Area Materno Infantil

Servicio de Endocrinología Pediátrica

Ulteriori dettagli